For patients with low-risk prostate cancer managed with active surveillance, obesity may increase risk of progression
the ONA take:
According to a new study published in the journal European Urology, researchers have found that obesity is linked with an increased risk of progression of low-risk prostate cancers in patients that are managed by active surveillance.
For the study, the researchers identified 565 men undergoing active surveillance for low-risk prostate cancer. The researchers found that during the median follow-up of 48 months, 168 men (30%) experienced pathologic progression and 172 men (30%) experienced therapeutic progression.
They did not find an association between obesity and risk of progression at the time of confirmatory biopsy, but beyond that, obesity was linked with an increased risk of pathologic progression (P = 0.007) and therapeutic progression (P = 0.007).
For every 5 unit increase in body mass index (BMI), the risk of pathologic progression increases (HR = 1.5, 95% CI: 1.1-2.1, P = 0.02). Similarly, the risk of therapeutic progression increases in the same manner (HR = 1.4, 95% CI: 1.0-1.9, P = 0.05).
Ultimately, the findings suggest that obesity is associated with a significantly elevated risk of prostate cancer progression after the confirmatory biopsy.
Obesity linked with increased risk of progression of low-risk prostate cancers in active surveillance.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|